• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX HEMOCONCENTRATOR; DIALYZER, HIGH PERMEABILITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX HEMOCONCENTRATOR; DIALYZER, HIGH PERMEABILITY Back to Search Results
Catalog Number ZZ*HC11S
Device Problem Complete Blockage (1094)
Patient Problems No Consequences Or Impact To Patient (2199); Blood Loss (2597)
Event Date 06/07/2017
Event Type  malfunction  
Manufacturer Narrative
Udi number for this product code is not required.The actual device has not been returned to the manufacturing facility for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.A review of the device history record and shipping inspection record of the involved product code/lot number combination was conducted with no relevant findings.A search of the complaint file found no other report with the involved product code/lot# combination.(b)(4).All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported clogging in the capiox device during a procedure.Follow up information provided by the user facility reported the following: the hemoconcentrator was built into a custom pack adult cx-be092x, lot 1608291; bypass was started with the custom pack; filtering with the hemoconcentrator was started without problem; the perfusionist closed the clamp of the hemoconcentrator for giving the cardioplegia; the moment that the clamp was opened to restart the filtering, it was noticed that the hemoconcentrator was obstructed; no flow could pass through the device; the perfusionist remove the hemoconcentrator and exchange with another device; the surgeon did not experience any problem or delay due to the issue; the only lost blood was the blood in the partly filled hemoconcentrator; and the patient was not harmed.
 
Manufacturer Narrative
The actual device was returned to the manufacturing facility for evaluation.Visual inspection found no obvious anomalies.The actual sample was rinsed and another visual inspection focusing on the state of the fiber was conducted.No anomalies were noted.The actual sample was built into a circuit.Bovine blood was let to flow through the tubes.It was confirmed, an adequate blood flow rate was achieved.The pressure loss was determined while bovine blood was circulated in the circuit at the flow rate of 500ml/min.And tmp400mmhg.The obtained values were confirmed to meet manufacturing specification.No anomalies or no obstruction was confirmed.There is no evidence that this event was related to a device defect or malfunction.The investigation results verified the actual sample was normal product with no issue in the gas transfer performance.While the exact cause of the reported event cannot be definitively determined based on the available information, clots may have formed inside the fiber preventing blood from flowing in the normal manner.The device labeling does address the potential for such an event in the instructions-for-use (ifu) with statements such as the following: the capiox hemoconcentrator is designed to operate at flow rate within the range of 100 to 500ml/min during ultrafiltration.Do not use blood flow rates outside this range.Less than 100ml/min blood flow may cause blood coagulation in the device.Do not exceed 50% hematocrit at the blood outlet during ultrafiltration.Do not stop blood flow during extracorporeal circulation as it may cause clotting in the system.A blood flow of least 50ml/min is recommended even if ultrafiltration is stopped by clamping the filtrate line.Bubbles in the system may cause clotting and blood damage.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX HEMOCONCENTRATOR
Type of Device
DIALYZER, HIGH PERMEABILITY
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
terry callahan
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key6685325
MDR Text Key79066461
Report Number9681834-2017-00131
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K973516
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Catalogue NumberZZ*HC11S
Device Lot Number160426
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/05/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/07/2017
Initial Date FDA Received07/04/2017
Supplement Dates Manufacturer Received07/05/2017
Supplement Dates FDA Received08/03/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/26/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age76 YR
Patient Weight95
-
-